Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Vet
Pets & Animals/Pet Medications

TEVA Animal Health Inc: Various Veterinary Tablets Recalled for Physical Characteristic Defects

Agency Publication Date: September 1, 2009
Share:
Sign in to monitor this recall

Summary

TEVA Animal Health Inc. is recalling 400,413 units of various veterinary medications including Levothyroxine Sodium, Phenylbutazone, Praziquantel, and Clindamycin Hydrochloride due to physical characteristic defects in the tablets. These medications are used to treat conditions such as thyroid issues, pain, and infections in animals, and the physical defects could impact the accuracy of the dosage or the effectiveness of the treatment. The affected products were distributed nationwide across the United States primarily to own-label distributors, veterinary drug distributors, and veterinary clinics. Owners should immediately consult their veterinarian if their pet is taking any of these specific medications.

Risk

The tablets have physical characteristic defects which may lead to incorrect dosing or inconsistent medication delivery, potentially resulting in under-treatment or over-treatment of the animal's underlying medical condition.

What You Should Do

  1. Check your pet's medication packaging to see if it matches any of the following brands: AmTech Group Inc., Phoenix Pharmaceutical (Thyrozine, CestaTabs, Phenylbute), Butler (ButaTabs, Clincaps, Prazitabs), VEDCO (ClindaCure, Cestoved, Bute Tabs), Pro Labs (Pro-Bute), Trade Winds (Tape Worm Tabs), Farnam (D-Worm), or A & G Pharmaceuticals.
  2. Identify the specific medication and dosage, such as Levothyroxine (0.2 mg, 0.5 mg, 0.8 mg), Phenylbutazone (1 g, 100 mg), Praziquantel (34 mg), or Clindamycin (25 mg, 75 mg, 150 mg, 300 mg).
  3. Look for the following Recall Numbers on your records or packaging: V-260-2009 through V-269-2009.
  4. Immediately contact your veterinarian or healthcare provider to discuss alternative treatments and to determine if your pet's health has been affected by the defective medication.
  5. Return any unused portions of the medication to the veterinary clinic or pharmacy where you purchased it for a refund and further instructions.
  6. Contact the manufacturer, TEVA Animal Health Inc., at their Saint Joseph, Missouri location for additional information regarding this recall.
  7. For further questions or to report issues, contact the FDA Center for Veterinary Medicine at 1-240-402-7002.

Your Remedy Options

💰Full Refund

Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

How to: Contact your veterinarian to discuss the defect. Return unused medications to the place of purchase for a full refund and contact TEVA Animal Health Inc. for further instructions.

Affected Products

Product: AmTech Group Inc. Levothyroxine Sodium Tablets 0.2 mg (180- and 1,000-tablet bottles)
Model:
V-260-2009
Product: Phoenix Pharmaceutical, Inc. Thyrozine 0.2 mg (180- and 1,000-tablet bottles)
Model:
V-260-2009
Product: AmTech Group Inc. Levothyroxine Sodium Tablets 0.5 mg (180- and 1,000-tablet bottles)
Model:
V-261-2009
Product: Phoenix Pharmaceutical, Inc. Thyrozine 0.5 mg (180- and 1,000-tablet bottles)
Model:
V-261-2009
Product: AmTech Group Inc. Levothyroxine Sodium Tablets 0.8 mg (180- and 1,000-tablet bottles)
Model:
V-262-2009
Product: Phoenix Pharmaceutical, Inc. Thyrozine 0.8 mg (180- and 1,000-tablet bottles)
Model:
V-262-2009
Product: Phenylbutazone Tablets 1 g (100-tablet bottles) - Multiple Brands
Model:
V-263-2009
Product: Phenylbutazone Tablets 100 mg (1,000-tablet bottles) - Multiple Brands
Model:
V-264-2009
Product: Praziquantel Tablets 34 mg - Multiple Brands
Model:
V-265-2009
Product: Clindamycin Hydrochloride Capsules 25 mg (600-count bottles)
Model:
V-266-2009
Product: Clindamycin Hydrochloride Capsules 75 mg (200-count bottles)
Model:
V-267-2009
Product: Clindamycin Hydrochloride Capsules 150 mg (100-count bottles)
Model:
V-268-2009
Product: Clindamycin Hydrochloride Capsules 300 mg (100-count bottles)
Model:
V-269-2009

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 51930
Status: Resolved
Manufacturer: TEVA Animal Health Inc
Sold By: own-label distributors; vet drug distributors; vet clinics; Butler Animal Health Supply; Clipper Distributing Co., LLC; VEDCO, Inc.; RXVeterinary Products
Manufactured In: United States
Units Affected: 10 products (5,382/180-ct. btls and 5,529/1,000-ct. btls.; 5,649/180-ct. btls. and 5,199/1,000-ct. btls.; 11,114/180-ct. btls. and 12,025/1,000-ct. btls.; 89,326/100-ct. btls.; 2,774/1,000-ct. btls.; 216,690/5-ct.; 125,430/10-ct.; 18,498/50-ct.; 10,617/150-ct.; 18,250/600-ct. btls.; 35,417/200-ct. btls.; 9,898/100-ct. btls.; 5,913/100-ct. btls.)
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response